VEGFA and metabolic syndrome: The interaction of VEGF 1451C > T and MetS contributed to increased RC risk (AOR = 3.15; 95% CI = 1.74 - 5.70; p < .001) whereas the combination of VEGF 1725G > A and MetS was involved with elevated CC risk (AOR = 2.68; 95% CI =1.30 - 1.55; p = 0.008).